Leyden Laboratories B.V. (the “Company” or “Leyden Labs”) today announced positive results from a Phase 1 study of RIG-101, an investigational intranasal innate immune modulator being developed to prevent the consequences of common respiratory viral infections in vulnerable patients. Results…
A new place for coffee, breakfast, lunch and drinks is coming to Leiden Bio Science Park. On 1September, Vascobelo V-Bar Leiden Bio Science Park will officially open its doors at Einsteinweg4D, in the new MORE development area. Located opposite Leiden…
BioMarin Pharmaceutical Inc. (BioMarin) has agreed to acquire Alesta Therapeutics for $275 million upfront and up to $215 million in development and regulatory milestones, for a total of up to $490 million. The transaction has been approved by both companies’…
MIMETAS’ unique organ-on-a-chip and human tissue models complement Bruker’s multiomics, NMR, spatial biology and preclinical imaging solutions LEIDEN, The Netherlands–(BUSINESS WIRE)–Bruker Corporation (Nasdaq: BRKR) today announced a majority investment in MIMETAS B.V., a developer of organ-on-a-chip platforms and advanced human tissue…
Immunotherapy turns the body’s own immune system against cancer. It can be strikingly effective, but it has limits, and a LUMC team wants to push past them by combining two approaches that each engage the immune system in a different…
When a woman is treated for uterine cancer, the make-up of her tumour shapes the treatment plan, and increasingly that means asking a pathologist to run DNA analysis. One marker matters especially: a mutation in the POLE gene. Patients who…
Discharging a patient from intensive care too early raises the chance they’ll be readmitted, which comes with more complications and a higher risk of death. Keeping someone in the ICU longer than necessary carries its own dangers, including hospital-acquired infections.…
Leiden, 23 June 2026 What began as a graduation project at Leiden University of Applied Sciences has developed into a successful biotech start-up and a long-term partnership. Leiden University of Applied Sciences and Bionomic B.V. have officially renewed their collaboration…
A contribution from Expedition Urban Nature 2026, with thanks to biologist Ben Wielstra of Leiden University and Naturalis On Saturday, 16 May, at 9:00 in the morning, interested participants gathered in the gardens of the Hortus botanicus Leiden for the…
In May and June, 2,636 residents of Leiden, Leiderdorp, Oegstgeest and Katwijk jointly spotted 3,939 species of plants, animals and fungi. From seagulls to sea sparkle, from water beetles to plantain, everything was recorded to help map urban nature. Particularly…
LEIDEN, Netherlands and CAMBRIDGE, Mass., June 25, 2026 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a clinical-stage biotechnology company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the pricing…
LEIDEN, Netherlands & CAMBRIDGE, Mass., June 25, 2026 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR or the Company), a clinical-stage biotechnology company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology…